STAT3 |
MCF10A (breast epithelial cells) |
(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000DPB
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
IL-6, IL-23 |
Permissive
Robust
|
Mus musculus |
GSE23681
...
|
MA0144.2
|
STAT3 |
dendritic cells |
IL21 |
Permissive
Robust
|
Mus musculus |
GSE27161
...
|
MA0144.2
|
STAT3 |
dendritic cells |
IL-21 and GM-CSF |
Permissive
Robust
|
Mus musculus |
GSE27161
...
|
MA0144.2
|
STAT3 |
adherent peritoneal exudate macrophages |
Il10 |
Permissive
|
Mus musculus |
GSE31529
...
|
MA0144.2
|
STAT3 |
dendritic cells |
LPS, 0 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0144.2
|
STAT3 |
dendritic cells |
LPS, 120 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0144.2
|
STAT3 |
dendritic cells |
LPS, 60 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0144.2
|
STAT3 |
AtT-20 (pituitary tumor) |
LIF |
Permissive
Robust
|
Mus musculus |
GSE37235
...
|
MA0144.2
|
STAT3 |
AtT-20 (pituitary tumor) |
Dex+LIF |
Permissive
Robust
|
Mus musculus |
GSE37235
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
IL21 |
Permissive
Robust
|
Mus musculus |
GSE39756
...
|
MA0144.2
|
STAT3 |
gastric tumors |
PBS |
Permissive
|
Mus musculus |
GSE48285
...
|
MA0144.2
|
STAT3 |
gastric tumors |
IL6 |
Permissive
|
Mus musculus |
GSE48285
...
|
MA0144.2
|
STAT3 |
gastric tumors |
IL11 |
Permissive
|
Mus musculus |
GSE48285
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
IL21 |
Permissive
|
Mus musculus |
GSE63204
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
Stat1 KO, IL21 |
Permissive
|
Mus musculus |
GSE63204
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL6) |
Permissive
Robust
|
Mus musculus |
GSE65621
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL27) |
Permissive
Robust
|
Mus musculus |
GSE65621
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
3 day in vitro culture for Th0, STAT1 KO |
Permissive
|
Mus musculus |
GSE65621
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL6), STAT1 KO |
Permissive
Robust
|
Mus musculus |
GSE65621
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL27), STAT1 KO |
Permissive
Robust
|
Mus musculus |
GSE65621
...
|
MA0144.2
|
STAT3 |
dendritic cells |
SAHA (500nm) |
Permissive
|
Mus musculus |
GSE74262
...
|
MA0144.2
|
STAT3 |
mammary gland |
lactation day one |
Permissive
|
Mus musculus |
GSE84115
...
|
MA0144.2
|
STAT3 |
mammary gland |
involution 12 hours |
Permissive
Robust
|
Mus musculus |
GSE84115
...
|
MA0144.2
|
STAT3 |
mammary gland |
involution 24 hours |
Permissive
Robust
|
Mus musculus |
GSE84115
...
|
MA0144.2
|
STAT3 |
MDA-MB-157 (triple negative breast carcinoma) |
ethanol |
Permissive
Robust
|
Homo sapiens |
GSE85579
...
|
MA0144.2
|
STAT3 |
MDA-MB-231 (breast adenocarcinoma) |
ethanol |
Permissive
Robust
|
Homo sapiens |
GSE85579
...
|
MA0144.2
|
STAT3 |
HCC1143 (ductal breast carcinoma) |
ethanol |
Permissive
|
Homo sapiens |
GSE85579
...
|
MA0144.2
|
STAT3 |
HCC70 (ductal breast carcinoma) |
ethanol |
Permissive
Robust
|
Homo sapiens |
GSE85579
...
|
MA0144.2
|
STAT3 |
MDA-MB-468 (breast adenocarcinoma) |
ethanol |
Permissive
Robust
|
Homo sapiens |
GSE85579
...
|
MA0144.2
|
STAT3 |
bone marrow-derived macrophages |
30min IL-10 |
Permissive
Robust
|
Mus musculus |
GSE86169
...
|
MA0144.2
|
STAT3 |
bone marrow-derived macrophages |
195min LPS |
Permissive
|
Mus musculus |
GSE86169
...
|
MA0144.2
|
STAT3 |
bone marrow-derived macrophages |
195min LPS + 30min IL-10 |
Permissive
Robust
|
Mus musculus |
GSE86169
...
|
MA0144.2
|
STAT3 |
primary cortical oligodendrocyte progenitors |
100ng/ml of CNTF (Peprotech) for 15 m |
Permissive
Robust
|
Mus musculus |
GSE99708
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
IRF4 KO; pre IL21 |
Permissive
|
Mus musculus |
GSE19198
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
IRF4 KO; post IL21 |
Permissive
|
Mus musculus |
GSE19198
...
|
MA0144.2
|
STAT3 |
Th17-cells |
16h |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
3h |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
STAT3 ko |
Permissive
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
RORg wt |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
RORg ko |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
RORg wt |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
RORg ko |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
spleen T cells |
CD4 |
Permissive
|
Mus musculus |
GSE102317
...
|
MA0144.2
|
STAT3 |
spleen T cells |
IL-21 (100 ng/ml) for 1h, CD4 |
Permissive
Robust
|
Mus musculus |
GSE102317
...
|
MA0144.2
|
STAT3 |
TMD8 (diffuse large B-cell lymphoma) |
DMSO |
Permissive
|
Homo sapiens |
GSE106844
...
|
MA0144.2
|
STAT3 |
TMD8 (diffuse large B-cell lymphoma) |
AZD1480(JAK inhibitor) for 4hrs |
Permissive
|
Homo sapiens |
GSE106844
...
|
MA0144.2
|
STAT3 |
OCI-LY10 (diffuse large B-cell lymphoma) |
DMSO |
Permissive
|
Homo sapiens |
GSE106844
...
|
MA0144.2
|
STAT3 |
OCI-LY10 (diffuse large B-cell lymphoma) |
AZD1480(JAK inhibitor) for 4hrs |
Permissive
|
Homo sapiens |
GSE106844
...
|
MA0144.2
|
STAT3 |
MCF10A-ER-Src |
Genotype: non-transformed |
Permissive
Robust
|
Homo sapiens |
GSE115597
...
|
MA0144.2
|
STAT3 |
MCF10A-ER-Src |
Genotype: transformed |
Permissive
Robust
|
Homo sapiens |
GSE115597
...
|
MA0144.2
|
STAT3 |
EML -C1(EML, clone 1) |
Strain: B6D2F1 Genotype: CD34 positive |
Permissive
|
Mus musculus |
GSE100689
...
|
MA0144.2
|
STAT3 |
kidney |
WT; lactation day 10 |
Permissive
|
Mus musculus |
GSE115368
...
|
MA0144.2
|
STAT3 |
kidney |
Wap-E12-Ramp3; lactation day 10 |
Permissive
|
Mus musculus |
GSE115368
...
|
MA0144.2
|
STAT3 |
AtT-20 (pituitary tumor) |
Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo |
Permissive
Robust
|
Mus musculus |
GSE87180
...
|
MA0144.2
|
STAT3 |
AtT-20 (pituitary tumor) |
Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 |
Permissive
Robust
|
Mus musculus |
GSE87180
...
|
MA0144.2
|
STAT3 |
AtT-20 (pituitary tumor) |
Treatment: 30 minutes of LIF and Dexamethasone, >20 days of 4-hydroxy-tamoxifen Cell type: Genotype:3x flag-ER-Pax8 Cell type: pituitary corticotroph cell Passage: 10-20 |
Permissive
Robust
|
Mus musculus |
GSE87180
...
|
MA0144.2
|
STAT3 |
AtT-20 (pituitary tumor) |
Treatment: 30 minutes of LIF and Dexamethasone, >20 days of 4-hydroxy-tamoxifen followed by 18 days of Ethanol treatment Cell type: Genotype:3x flag-ER-Pax9 Cell type: pituitary corticotroph cell Passage: 10-20 |
Permissive
Robust
|
Mus musculus |
GSE87180
...
|
MA0144.2
|
STAT3 |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: DN-NFkB for 2 hr |
Permissive
|
Mus musculus |
GSE96767
...
|
MA0144.2
|
STAT3 |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) + DN-NFkB for 2 hr |
Permissive
|
Mus musculus |
GSE96767
...
|
MA0144.2
|
STAT3 |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-6 (10ng/ml) + DN-NFkB for 2 hr |
Permissive
Robust
|
Mus musculus |
GSE96767
...
|
MA0144.2
|
STAT3 |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) and IL-6 (10ng/ml) + DN-NFkB for 2 hr |
Permissive
Robust
|
Mus musculus |
GSE96767
...
|
MA0144.2
|
STAT3 |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) for 2 hr |
Permissive
Robust
|
Mus musculus |
GSE96767
...
|
MA0144.2
|
STAT3 |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-6 (10ng/ml) for 2 hr |
Permissive
Robust
|
Mus musculus |
GSE96767
...
|
MA0144.2
|
STAT3 |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) and IL-6 (10ng/ml) for 2 hr |
Permissive
Robust
|
Mus musculus |
GSE96767
...
|
MA0144.2
|
STAT3 |
JB6 (Human anaplastic large cell lymphoma) |
Treatment: DMSO for 3 hrs |
Permissive
Robust
|
Homo sapiens |
GSE117164
...
|
MA0144.2
|
STAT3 |
JB6 (Human anaplastic large cell lymphoma) |
Treatment: 300 nM Crizotinib for 3 hrs |
Permissive
Robust
|
Homo sapiens |
GSE117164
...
|
MA0144.2
|
STAT3 |
SU-DHL-1 (Anaplastic large cell lymphoma) |
Treatment: DMSO for 3 hrs |
Permissive
Robust
|
Homo sapiens |
GSE117164
...
|
MA0144.2
|
STAT3 |
SU-DHL-1 (Anaplastic large cell lymphoma) |
Treatment: 300 nM Crizotinib for 3 hrs |
Permissive
Robust
|
Homo sapiens |
GSE117164
...
|
MA0144.2
|
STAT3 |
cultured GC B cells |
Genotype: STAT3 wildtype Strain: C57BL/6 |
Permissive
|
Mus musculus |
GSE120022
...
|
MA0144.2
|
STAT3 |
gastric tumors |
Treatment: PBS; Age: 10-12 weeks; Genotype: gp130F/F; |
Permissive
|
Mus musculus |
GSE48287
...
|
MA0144.2
|
STAT3 |
gastric tumors |
Treatment: IL6; Age: 10-12 weeks; Genotype: gp130F/F; |
Permissive
Robust
|
Mus musculus |
GSE48287
...
|
MA0144.2
|
STAT3 |
gastric tumors |
Treatment: IL11; Age: 10-12 weeks; Genotype: gp130F/F; |
Permissive
Robust
|
Mus musculus |
GSE48287
...
|
MA0144.2
|
STAT3 |
inducible motor neuron embryonic stem cells |
Treatment: without Doxycycline treatment; |
Permissive
|
Mus musculus |
GSE50993
...
|
MA0144.2
|
STAT3 |
inducible motor neuron embryonic stem cells |
Treatment: without Doxycycline treatment; |
Permissive
|
Mus musculus |
GSE50993
...
|
MA0144.2
|
STAT3 |
inducible motor neuron embryonic stem cells |
Treatment: Doxycycline treatment; |
Permissive
|
Mus musculus |
GSE50993
...
|
MA0144.2
|
STAT3 |
pre-activated CD4+ T cells |
Treatment: none (untreated); Tissue: Spleen; Strain: C57BL/6; |
Permissive
|
Mus musculus |
GSE61677
...
|
MA0144.2
|
STAT3 |
pre-activated CD4+ T cells |
Treatment: IL-21 for 1hr; Tissue: Spleen; Strain: C57BL/6; |
Permissive
|
Mus musculus |
GSE61677
...
|
MA0144.2
|
STAT3 |
splenic conventional dendritic cells |
Treatment: none (untreated); Tissue: Spleen; Strain: C57BL/6; |
Permissive
|
Mus musculus |
GSE61677
...
|
MA0144.2
|
STAT3 |
splenic conventional dendritic cells |
Treatment: IL-21 for 1hr; Tissue: Spleen; Strain: C57BL/6; |
Permissive
|
Mus musculus |
GSE61677
...
|
MA0144.2
|
STAT3 |
HeLa S3 (cervical adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EDC
|
MA0144.2
|
STAT3 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE26552
...
|
MA0144.2
|
STAT3 |
Th17-cells |
|
Permissive
|
Mus musculus |
GSE21669
...
|
MA0144.2
|
STAT3 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE11431
...
|
MA0144.2
|
STAT3 |
dendritic cells |
|
Permissive
|
Mus musculus |
GSE27161
...
|
MA0144.2
|
STAT3 |
adherent peritoneal exudate macrophages |
|
Permissive
|
Mus musculus |
GSE31529
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE39756
...
|
MA0144.2
|
STAT3 |
Th17-cells |
|
Permissive
|
Mus musculus |
GSE39756
...
|
MA0144.2
|
STAT3 |
astrocytes |
|
Permissive
Robust
|
Mus musculus |
GSE51281
...
|
MA0144.2
|
STAT3 |
dendritic cells |
|
Permissive
|
Mus musculus |
GSE74262
...
|
MA0144.2
|
STAT3 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0144.2
|
STAT3 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0144.2
|
STAT3 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0144.2
|
STAT3 |
Th17-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE67183
...
|
MA0144.2
|
STAT3 |
A139 ER-, PR-, HER2- breast cancer cells |
N/A |
Permissive
|
Homo sapiens |
GSE85579
...
|
MA0144.2
|
STAT3 |
A137 ER-, PR-, HER2- breast cancer cells |
N/A |
Permissive
|
Homo sapiens |
GSE85579
...
|
MA0144.2
|
STAT3 |
bone marrow-derived macrophages |
|
Permissive
|
Mus musculus |
GSE86169
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE19198
...
|
MA0144.2
|
STAT3 |
CD4+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE19198
...
|
MA0144.2
|
STAT3 |
Th0-cells |
|
Permissive
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0144.2
|
STAT3 |
NCI-H358 (human nnon small cell lung cancer cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE79707
...
|
MA0144.2
|
STAT3 |
AGS (gastric adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE79707
...
|
MA0144.2
|
STAT3 |
WA01 (H1, human embryonic stem cells) |
|
Permissive
|
Homo sapiens |
ERP004237
|
MA0144.2
|
STAT3 |
OCI-LY10 (diffuse large B-cell lymphoma) |
|
Permissive
|
Homo sapiens |
GSE50723
|
MA0144.2
|
STAT3 |
OCI-LY19 (diffuse large B-cell lymphoma) |
|
Permissive
|
Homo sapiens |
GSE50723
|
MA0144.2
|
STAT3 |
OCI-LY3 (diffuse large B-cell lymphoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE50723
|
MA0144.2
|
STAT3 |
SU-DHL-2 (anaplastic large cell lymphoma) |
|
Permissive
|
Homo sapiens |
GSE50723
|
MA0144.2
|
STAT3 |
SU-DHL-6 (diffuse large B-cell lymphoma) |
|
Permissive
|
Homo sapiens |
GSE50723
|
MA0144.2
|
STAT3 |
U2932 (diffuse large B-cell lymphoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE50723
|
MA0144.2
|
STAT3 |
hFOB 1.19 (fetal osteoblast) |
|
Permissive
|
Homo sapiens |
GSE82295
|
MA0144.2
|